BTIG analyst Vincent Caintic maintained a Buy rating on Affirm Holdings (AFRM – Research Report) yesterday and set a price target of $81.00.
BTIG analyst Carl Reichardt Jr. maintained a Neutral rating on shares of NVR Inc . (NYSE:NVR), while slightly lowering ...
Hosted on MSN1d
BTIG Initiates Coverage of Arcturus Therapeutics Holdings (ARCT) with Buy RecommendationFintel reports that on January 28, 2025, BTIG initiated coverage of Arcturus Therapeutics Holdings (NasdaqGM:ARCT) with a Buy ...
In a report released yesterday, Carl Reichardt from BTIG maintained a Hold rating on NVR (NVR – Research Report). The company’s shares closed ...
Market technician Jonathan Krinsky analyzes the shift in market leadership from technology to healthcare amid recent ...
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the BTIG Annual MedTech, Digital Health, Life Science ...
Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...
Shares of AppLovin Co. (NASDAQ:APP – Get Free Report) rose 6.3% on Tuesday after The Goldman Sachs Group raised their price target on the stock from $220.00 to $335.00. The Goldman Sachs Group ...
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the 12th Annual BTIG MedTech, Digital Health, ...
What damage might Monday's ongoing selloff do to the technical set-up for stocks? Well, in a note published on Sunday, BTIG chartist guru Jonathan Krinsky observed that Friday's action had already sug ...
Adaptive Biotechnologies (NASDAQ:ADPT – Get Free Report) had its price objective increased by equities research analysts at The Goldman Sachs Group from $5.50 to $7.50 in a note issued to investors on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback